Synonyms: VX993
VX-993 is an approved drug
Compound class:
Synthetic organic
Comment: VX-993 is an orally bioavailable NaV1.8 ion channel inhibitor [1]. NaV1.8 is a validated target for the development of non-opioid analgesics.
|
|
References |
1. Beck EM. (2022)
N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamide analogs as modulators of sodium channels. Patent number: WO2022256679A1. Assignee: Vertex Pharmaceuticals Incorporated. Priority date: 03/06/2022. Publication date: 08/12/2022. |